Fragment-based discovery of hepatitis C virus NS5b RNA polymerase inhibitors
about
Fragment-based screening by X-ray crystallography, MS and isothermal titration calorimetry to identify PNMT (phenylethanolamine N-methyltransferase) inhibitorsAnomalous dispersion analysis of inhibitor flexibility: a case study of the kinase inhibitor H-89Creating novel activated factor XI inhibitors through fragment based lead generation and structure aided drug designTarget immobilization as a strategy for NMR-based fragment screening: comparison of TINS, STD, and SPR for fragment hit identification.Integrating surface plasmon resonance biosensor-based interaction kinetic analyses into the lead discovery and optimization process.Biosensor-based small molecule fragment screening with biolayer interferometry.The benefits of constructing leads from fragment hits.Emerging role of surface plasmon resonance in fragment-based drug discovery.A ligand-observed mass spectrometry approach integrated into the fragment based lead discovery pipeline.Structure-activity relationships in the development of allosteric hepatitis C virus RNA-dependent RNA polymerase inhibitors: ten years of research.A study of the allosteric inhibition of HCV RNA-dependent RNA polymerase and implementing virtual screening for the selection of promising dual-site inhibitors with low resistance potential.Combination of pharmacophore hypothesis and molecular docking to identify novel inhibitors of HCV NS5B polymerase.
P2860
Q27663569-6B784F36-97CD-4AD2-A3B1-D76405900CB3Q27671230-8720B018-9C3F-445F-9721-8E7A6342B765Q28543133-507DC543-88FE-4B7C-84FA-CE6D6669B9DAQ33684605-A4168120-4B69-44DC-AB2B-FA68945B5B99Q33852386-27B3C86A-190F-49C0-BE21-431B6E12ADE9Q33928781-4567C06A-3582-41E7-B51D-9BD3356FCE8AQ33977454-EB3953B8-BCA3-485C-8DAE-ED5231242E11Q34049517-62D759CE-A8FD-42B3-8045-F355B6A99A4AQ35065764-3D6A7D0B-BF7B-4DF5-8B9F-8D42619ADD23Q38034733-D7B9BAE2-DCF2-4F4C-9C27-F3F1CE66BA42Q38796994-238C3FEC-D854-4F8E-904C-7FE0112BCB84Q38888719-DD290FB6-2572-417F-8F06-A773F3E948F7
P2860
Fragment-based discovery of hepatitis C virus NS5b RNA polymerase inhibitors
description
2008 nî lūn-bûn
@nan
2008 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Fragment-based discovery of hepatitis C virus NS5b RNA polymerase inhibitors
@ast
Fragment-based discovery of hepatitis C virus NS5b RNA polymerase inhibitors
@en
Fragment-based discovery of hepatitis C virus NS5b RNA polymerase inhibitors
@nl
type
label
Fragment-based discovery of hepatitis C virus NS5b RNA polymerase inhibitors
@ast
Fragment-based discovery of hepatitis C virus NS5b RNA polymerase inhibitors
@en
Fragment-based discovery of hepatitis C virus NS5b RNA polymerase inhibitors
@nl
prefLabel
Fragment-based discovery of hepatitis C virus NS5b RNA polymerase inhibitors
@ast
Fragment-based discovery of hepatitis C virus NS5b RNA polymerase inhibitors
@en
Fragment-based discovery of hepatitis C virus NS5b RNA polymerase inhibitors
@nl
P2093
P1476
Fragment-based discovery of hepatitis C virus NS5b RNA polymerase inhibitors
@en
P2093
Anthony M Giannetti
Brandon Aubol
Brian Nolan
Charles Kissinger
Eduardo Torres
Elizabeth Jefferson
Ethel McGee
Isabel Nájera
Jeff Blaney
Jörg Hendle
P304
P356
10.1016/J.BMCL.2008.03.056
P407
P577
2008-05-01T00:00:00Z